| |
| |
|
| Insider
Information: |
Rastetter William H |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
225,281 |
|
|
Indirect Shares
|
1,517,593 |
|
|
| Direct
Value |
$20,084,217 |
|
|
|
Indirect Value
|
$99,018,555 |
|
|
| Total
Shares |
1,742,874 |
|
|
| Total
Value |
$119,102,771 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biogen Idec Inc |
BIIB |
Executive Chairman, Di... |
2005-02-23 |
50,676 |
2005-02-23 |
373,929 |
Premium* |
|
|
Illumina Inc |
ILMN |
Director |
2015-12-31 |
8,494 |
2015-12-31 |
86,680 |
Premium* |
|
|
Receptos, Inc. |
RCPT |
Director |
2015-08-27 |
0 |
2015-08-25 |
0 |
Premium* |
|
|
Fate Therapeutics Inc |
FATE |
Director |
2022-06-09 |
11,331 |
2022-06-09 |
606,093 |
Premium* |
|
|
Dare Bioscience Inc |
DARE |
Director |
2017-01-03 |
103,039 |
2014-04-15 |
60,307 |
Premium* |
|
|
Regulus Therapeutics Inc. |
RGLS |
Director |
2015-07-20 |
0 |
2020-02-03 |
390,584 |
Premium* |
|
|
Neurocrine Biosciences Inc |
NBIX |
Director |
2024-01-02 |
51,741 |
2017-02-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
105 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2017-02-01 |
4 |
OE |
$2.17 |
$54,250 |
D/D |
25,000 |
25,000 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2010-09-22 |
4 |
OE |
$3.25 |
$65,000 |
D/D |
20,000 |
25,800 |
0 |
- |
|
| FATE |
Fate Therapeutics Inc |
Director |
– • – |
2020-03-30 |
4 |
OE |
$1.37 |
$38,992 |
D/D |
28,461 |
28,461 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2013-04-08 |
4 |
OE |
$1.04 |
$20,700 |
D/D |
20,000 |
30,287 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2013-10-28 |
4 |
OE |
$3.24 |
$64,800 |
D/D |
20,000 |
32,808 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2022-04-01 |
4 |
AS |
$94.93 |
$1,018,366 |
D/D |
(10,728) |
34,022 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2018-01-24 |
4 |
OE |
$7.05 |
$141,000 |
D/D |
20,000 |
34,250 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2023-04-19 |
4 |
AS |
$105.00 |
$94,819 |
D/D |
(903) |
34,729 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2023-04-19 |
4 |
OE |
$12.71 |
$20,463 |
D/D |
1,610 |
35,632 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Director |
– • – |
2015-07-20 |
4 |
B |
$10.13 |
$392,779 |
I/I |
38,765 |
38,765 |
2.1 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2023-04-21 |
4 |
AS |
$105.04 |
$633,787 |
D/D |
(6,034) |
39,460 |
0 |
% |
|
| DARE |
Dare Bioscience Inc |
Director |
– • – |
2014-04-15 |
4 |
A |
$0.00 |
$0 |
D/D |
41,438 |
41,438 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2023-05-01 |
4 |
AS |
$101.43 |
$436,135 |
D/D |
(4,300) |
42,785 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2022-04-01 |
4 |
OE |
$6.66 |
$133,200 |
D/D |
20,000 |
44,750 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2023-04-21 |
4 |
OE |
$12.71 |
$136,823 |
D/D |
10,765 |
45,494 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2023-05-01 |
4 |
OE |
$12.71 |
$96,914 |
D/D |
7,625 |
47,085 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Executive Chairman |
• • – |
2004-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
50,367 |
|
- |
|
| BIIB |
Biogen Idec Inc |
Executive Chairman |
• • – |
2004-02-06 |
4/A |
A |
$0.00 |
$0 |
D/D |
50,000 |
50,367 |
|
- |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2024-01-02 |
4 |
AS |
$131.47 |
$1,451,927 |
D/D |
(11,044) |
51,741 |
0 |
% |
|
| BIIB |
Biogen Idec Inc |
Executive Chairman |
• • – |
2004-03-17 |
4 |
D |
$0.00 |
$0 |
D/D |
(4,000) |
54,367 |
|
- |
|
| BIIB |
Biogen Idec Inc |
Executive Chairman |
• • – |
2004-03-17 |
4 |
OE |
$0.60 |
$4,834 |
D/D |
8,000 |
58,367 |
|
- |
|
| DARE |
Dare Bioscience Inc |
Director |
– • – |
2014-04-15 |
4 |
B |
$7.00 |
$132,083 |
I/I |
18,869 |
60,307 |
2.1 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2024-01-02 |
4 |
OE |
$12.98 |
$259,600 |
D/D |
20,000 |
62,785 |
0 |
- |
|
| DARE |
Dare Bioscience Inc |
Director |
– • – |
2016-10-03 |
4 |
A |
$1.02 |
$18,750 |
D/D |
18,382 |
78,689 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Executive Chairman |
• • – |
2004-05-24 |
4 |
S |
$62.51 |
$1,817,714 |
D/D |
(29,081) |
79,081 |
|
- |
|
105 Records found
|
|
Page 3 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
